Squarepoint Ops LLC Apellis Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

$96.1 Billion
Q3 2025

A detailed history of Squarepoint Ops LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 52,834 shares of APLS stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

52,834

Previous 329,392 83.96%

Holding current value

$1.07 Million

Previous $5.7 Million 79.04%

% of portfolio

0.0%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$17.42 - $28.65 $4.82 Million - $7.92 Million	-276,558 Reduced 83.96%	52,834 $1.2 Million
Q2 2025 Aug 27, 2025	SELL	$16.36 - $23.0 $1.86 Million - $2.61 Million	-113,401 Reduced 25.61%	329,392 $5.7 Million
Q2 2025 Aug 14, 2025	SELL	$16.36 - $23.0 $1.86 Million - $2.61 Million	-113,401 Reduced 25.61%	329,392 $5.7 Million
Q1 2025 Aug 27, 2025	BUY	$21.87 - $34.63 $2.48 Million - $3.93 Million	113,401 Added 34.43%	442,793 $9.68 Million
Q1 2025 May 15, 2025	BUY	$21.87 - $34.63 $6.03 Million - $9.55 Million	275,831 Added 165.21%	442,793 $9.68 Million

Q4 2024 Feb 14, 2025	BUY	$26.18 - $35.42 $2.01 Million - $2.71 Million	76,621 Added 84.81%	166,962 $5.33 Million
Q3 2024 Nov 14, 2024	BUY	$28.84 - $41.15 $838,753 - $1.2 Million	29,083 Added 47.48%	90,341 $2.61 Million
Q2 2024 Aug 14, 2024	BUY	$38.07 - $59.71 $2.33 Million - $3.66 Million	61,258 New	61,258 $2.35 Million
Q3 2022 Nov 14, 2022	BUY	$44.76 - $69.66 $2.27 Million - $3.53 Million	50,705 Added 100.65%	101,085 $6.9 Million
Q2 2022 Aug 15, 2022	BUY	$35.07 - $59.21 $1.09 Million - $1.84 Million	31,082 Added 161.06%	50,380 $2.28 Million
Q1 2022 May 16, 2022	BUY	$35.46 - $54.12 $684,307 - $1.04 Million	19,298 New	19,298 $981,000
Q3 2021 Nov 15, 2021	SELL	$31.4 - $69.84 $167,801 - $373,224	-5,344 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$40.9 - $64.9 $218,569 - $346,825	5,344 New	5,344 $338,000
Q4 2020 Feb 16, 2021	SELL	$30.79 - $57.2 $813,533 - $1.51 Million	-26,422 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$25.89 - $33.65 $94,032 - $122,216	3,632 Added 15.94%	26,422 $797,000
Q2 2020 Aug 14, 2020	BUY	$24.8 - $38.49 $317,415 - $492,633	12,799 Added 128.11%	22,790 $744,000
Q1 2020 May 15, 2020	SELL	$17.91 - $44.33 $185,690 - $459,613	-10,368 Reduced 50.93%	9,991 $268,000
Q4 2019 Feb 14, 2020	SELL	$22.1 - $30.8 $520,189 - $724,970	-23,538 Reduced 53.62%	20,359 $623,000
Q3 2019 Nov 14, 2019	SELL	$24.09 - $32.18 $484,281 - $646,914	-20,103 Reduced 31.41%	43,897 $1.06 Million
Q2 2019 Aug 14, 2019	BUY	$18.0 - $25.34 $322,002 - $453,307	17,889 Added 38.8%	64,000 $1.62 Million
Q1 2019 May 15, 2019	BUY	$12.81 - $19.82 $41,081 - $63,562	3,207 Added 7.47%	46,111 $899,000
Q4 2018 Feb 14, 2019	BUY	$11.47 - $18.71 $250,091 - $407,952	21,804 Added 103.34%	42,904 $566,000
Q3 2018 Nov 14, 2018	BUY	$16.57 - $21.03 $349,627 - $443,733	21,100 New	21,100 $375,000

Others Institutions Holding APLS

# of Institutions

330

Shares Held

124M

Call Options Held

4.15M

Put Options Held

769K

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.23B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Apellis Pharmaceuticals, Inc. Transaction History